N. Scott Fine - Jun 3, 2024 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Executive Officer, Director
Signature
/s/ N. Scott Fine
Stock symbol
CYTH
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
4
Date filed
6/5/2024, 05:08 PM
Previous filing
Oct 23, 2023
Next filing
Jul 22, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Option (Right to Buy) Award $0 +266K $0.00 266K Jun 3, 2024 Common Stock 266K $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a one year period in equal quarterly installments.